Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Review · October 15, 2022

Hedgehog Pathway Inhibitor Therapy for Patients With Basal Cell Naevus Syndrome or High-Frequency Basal Cell Carcinoma

Acta Dermato-Venereologica


Additional Info

Acta Dermato-Venereologica
Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma
Acta Derm Venereol 2022 Jun 21;102(2022)adv00741, BJA Verkouteren, KAE Sinx, MGHC Reinders, MJB Aarts, K Mosterd

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading